FilingReader Intelligence
Navamedic secures Nordic approvals for Parkinson's treatment device
August 13, 2025 at 02:01 PM UTC•By FilingReader AI
Navamedic ASA announced final national approvals for Flexilev in OraFID packaging in Norway, Sweden, and Denmark, with Orion Corporation securing Finnish clearance. This completes the approval process for the Nordic launch anticipated in October 2025.
OraFID is a patented mechanical device for precise minitablet dispensing in Parkinson's treatment.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
OSL:NAVA•Oslo Stock Exchange
News Alerts
Get instant email alerts when Navamedic ASA publishes news
Free account required • Unsubscribe anytime